Summary
The Fourier GR-2, unveiled in September 2024, is the second-generation humanoid from Shanghai-based Fourier, a company with deep rehabilitation-robotics heritage. It is sold to research and enterprise customers as an open development platform, with 53 degrees of freedom and 12-DOF dexterous hands.
The GR-2 stands 175 cm, weighs 63 kg and uses Fourier's FSA 2.0 actuators with up to 380 N·m peak torque, plus 12-DOF dexterous hands carrying six tactile-sensor arrays and a 3 kg single-arm load. It runs on the GRx development platform with support for ROS, NVIDIA Isaac Lab and MuJoCo, and offers VR teleoperation, lead-through programming and multimodal LLM integration. Fourier's rehabilitation division reaches more than 2,000 medical institutions across 40+ countries, giving it a distinctive healthcare distribution pathway; commercial focus is now shifting toward the GR-3 'Care-Bot'.
